申请人:Maruyama Minoru
公开号:US20110136788A1
公开(公告)日:2011-06-09
[Problem] The present invention aims to provide an agent for the prophylaxis or treatment of irritable bowel syndrome.
[Solving Means] An agent for the prophylaxis or treatment of irritable bowel syndrome, containing a compound having a TGR5 receptor agonist activity, a fused ring compound represented by the formula
wherein ring A is an optionally substituted aromatic ring, and ring B′ is a 5- to 9-membered ring having one or more substituents, or a salt thereof as an active ingredient.